Skip to main content
Clinical Trials/KCT0009080
KCT0009080
Not Yet Recruiting
N/A

Comparison of differences in hemodynamic changes according to general anesthesia induction doses of remimazolam (byfavoju) based on total body weight and lean body mass in patients with a body mass index of 30 or more: a multicenter clinical trial

Hallym University Medical Center- Chuncheon0 sites168 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Endocrine, nutritional and metabolic diseases
Sponsor
Hallym University Medical Center- Chuncheon
Enrollment
168
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Hallym University Medical Center- Chuncheon

Eligibility Criteria

Inclusion Criteria

  • Patients over 19 with a body mass index of 30 and above who are scheduled to undergo tracheal intubation and general anesthesia

Exclusion Criteria

  • a) Preoperative medications include antidepressants, anti\-epidemic, narcotic painkillers, and antiemetic medications
  • b) Patients with ASA\-PS 4 or higher
  • c) c) benzodiazepines flumazenil hypersensitivity
  • d) a patient's refusal
  • e) If the average arterial pressure is more than 110mmHg and the heart rate is more than 120 times per minute by taking the average blood pressure and heart rate measured in the ward as baseline values
  • f) a patient unable to measure blood pressure in the upper extremity
  • g) Patients with the same arm with a blood pressure gauge and intravenous route due to surgery or underlying disease
  • h) Measures to protect vulnerable persons: Vulnerable subjects (minors, pregnant women, inmates, elderly, hospital staff or medical school, nursing students, pharmaceutical company employees, terminally ill patients, mentally retarded persons and persons with disabilities who cannot express their intentions) are not included in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials